Mechanism and Prevention of Remote Organ Injury Following Ruptured Aortic Aneurysm
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00416000
Recruitment Status :
First Posted : December 27, 2006
Last Update Posted : May 21, 2014
University Health Network, Toronto
The Physicians' Services Incorporated Foundation
Information provided by (Responsible Party):
Thomas Lindsay, University Health Network, Toronto
It has been estimated that 80% of deaths from abdominal aortic aneurysms results from rupture. Endovascular Aneurysm Repair (EVAR) has been applied to RAAA (Ruptured Abdominal Aortic Aneurysm) patients with reports of improvements. Despite the use of EVAR, patients have developed complications with lung and kidney function. This study will investigate certain biochemical processes that will potentially reduce these complications. Knowledge gained from this study may also be used to further research in this field through larger studies.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
30 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Those undergoing AAA repair for elevtive and ruptured AAA by both EVAR and open methods.
Open/Elective EVAR patients
Patients who do not present with abdominal aortic aneurysms or ruptured abdominal aortic aneurysm